Immunovia AB (publ)
IMMVF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $187,488 | $207,447 | $178,844 | $52,069 |
| - Cash | $2,814 | $29,269 | $37,669 | $25,318 |
| + Debt | $2,157 | $467 | $110 | $680 |
| Enterprise Value | $186,831 | $178,645 | $141,285 | $27,431 |
| Revenue | $11 | $90 | $139 | $455 |
| % Growth | -88.1% | -35.3% | -69.5% | – |
| Gross Profit | $65 | $90 | $139 | $455 |
| % Margin | 607.8% | 100% | 100% | 100% |
| EBITDA | -$2,604 | -$19,718 | -$18,001 | $4,370 |
| % Margin | -24,348.6% | -21,908.9% | -12,950.4% | 960.4% |
| Net Income | -$3,150 | -$41,051 | -$57,792 | $3,070 |
| % Margin | -29,452% | -45,612.2% | -41,577% | 674.7% |
| EPS Diluted | -0.008 | -0.14 | -0.24 | 0.048 |
| % Growth | 94.1% | 41.7% | -600% | – |
| Operating Cash Flow | -$16,108 | -$18,143 | -$24,365 | -$28,278 |
| Capital Expenditures | -$5,559 | $0 | $0 | $0 |
| Free Cash Flow | -$21,667 | -$18,143 | -$24,365 | -$28,278 |